- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Acute Myelogenous Leukemia
Total 5299 results
-
medac GmbHCompleted
-
PETHEMA FoundationCompletedAcute Myeloblastic LeukaemiaSpain
-
AstraZenecaCompletedAcute Myeloid LeukaemiaJapan
-
Weill Medical College of Cornell UniversityTerminatedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Myelogenous LeukemiaUnited States
-
Indiana UniversityCompletedSarcoma | Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Neuroblastoma | Non-Hodgkins LymphomaUnited States
-
Hematology department of the 920th hospitalRecruitingRefractory/Relapse Acute Myeloid LeukemiaChina
-
Washington University School of MedicineBioLineRx, Ltd.CompletedMultiple Myeloma | Hodgkin Disease | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloproliferative Neoplasm | Hodgkin's Disease | Hodgkins DiseaseUnited States
-
GlaxoSmithKlineTerminatedLeukaemia, Myelocytic, AcuteUnited States, Australia, Canada
-
Mundipharma Research LimitedInnovative Therapies For Children with Cancer ConsortiumTerminatedRelapsed or Refractory T-cell Acute Lymphoblastic Leukaemia | B-cell Precursor Acute Lymphoblastic Leukaemia | T-cell Non-Hodgkin's LymphomaCzech Republic, Austria, France, Germany, Italy, United Kingdom
-
Assiut UniversityUnknownChronic Phase Chronic Myelogenous Leukemia
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaFrance, United States, Australia
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteUnited States
-
AstraZenecaCompletedAcute Myeloid LeukaemiaUnited Kingdom
-
National Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Vanderbilt-Ingram Cancer CenterAstex Pharmaceuticals, Inc.; Forma Therapeutics, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingRefractory Acute Myeloid Leukemia | Conditioning | Hematopoietic Stem Cell Transplantation | Relapse Leukemia
-
M.D. Anderson Cancer CenterNot yet recruitingRefractory Acute Leukemia | Relapsed Acute LeukemiaUnited States
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States, Spain, Korea, Republic of, Australia, Canada, Germany, France, United Kingdom, Italy
-
Stanford UniversityOrca Biosystems, Inc.RecruitingMyelodysplastic Syndromes | Myeloproliferative Disorders | Acute Leukemia | Chronic Myelogenous Leukemia | Allogeneic Hematopoietic Cell Transplantation (HCT) | Advanced Hematologic MalignanciesUnited States
-
National Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess Blasts in TransformationUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Eli Lilly and Company; Kanisa PharmaceuticalsCompletedMyelodysplastic Syndromes | LeukemiaUnited States, Israel
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Ehab L AtallahTerminatedRelapsed or Refractory Acute Lymphoblastic Leukemia | Mixed Phenotype Acute Leukemia | Relapsed or Refractory Lymphoblastic LymphomaUnited States
-
National Cancer Institute (NCI)Children's Oncology GroupCompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22... and other conditionsUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Solid Tumors | Acute Lymphoid Leukemia | Anemia, Refractory, With Excess of BlastsUnited States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeAustralia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Acute Myeloid Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Persistent DiseaseUnited States
-
National Cancer Institute (NCI)Childrens Oncology Group (COG); LLS PedAL LLCRecruitingDown Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy | Myelodysplastic...United States
-
Astex Pharmaceuticals, Inc.WithdrawnRelapsed/Refractory LeukemiasUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Astex Pharmaceuticals, Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
Hospices Civils de LyonCompletedChronic Myelogenous LeukemiaFrance
-
M.D. Anderson Cancer CenterCompletedChronic Myelogenous LeukemiaUnited States
-
Beth Israel Deaconess Medical CenterNational Institutes of Health (NIH); Teva Pharmaceuticals USATerminatedChronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedCHRONIC MYELOGENOUS LEUKEMIACanada, Australia, Spain, Argentina, France, Brazil
-
Kerman University of Medical SciencesTerminatedChronic Myelogenous LeukemiaIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaChina, Argentina, Russian Federation, Germany, Guatemala, Panama, Colombia, Mexico, Brazil, India, Poland, Venezuela
-
University of Massachusetts, WorcesterTerminatedChronic Myelogenous LeukemiaUnited States
-
BayerCompletedChronic Myelogenous LeukemiaUnited States, France
-
M.D. Anderson Cancer CenterCompletedChronic Myelogenous LeukemiaUnited States
-
New Mexico Cancer Care AllianceWithdrawnChronic Myelogenous LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaUnited States
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
University of Illinois at ChicagoCompletedAcute Myeloid Leukemia | Polycythemia Vera | Multiple Myeloma | Myelofibrosis | Acute Leukemia | Chronic Myelogenous Leukemia | Aplastic Anemia | Myeloproliferative Disorder | Hodgkin's Disease | Malignant Lymphoma | Lymphocytic LeukemiaUnited States
-
AstraZenecaTerminatedAcute Myeloid LeukaemiaUnited States, Australia
-
Cellectis S.A.WithdrawnAcute Myeloid Leukaemia
-
Hospices Civils de LyonCompleted